Respiratory Medicine
Volume 95, Issue 1 , Pages 78-82 , January 2001

The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures

Received 4 August 2000 ,Accepted 12 October 2000.

References 

    References
  1. Chalasani NP, Valdecanas M AL, Gopal AK. Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks. Chest. 1995;108:932–936
  2. Hickey RW, Bowman MJ, Smith GA. Utility of blood cultures in pediatric patients found to have pneumonia in the emergency department. Ann Emerg Med. 1996;27:721–725
  3. Woodhead MA, Arrowsmith J, Chamberlain-Webber R. The value of routine microbial investigations in community-acquired pneumonia. Respir Med. 1991;85:313–317
  4. Waterer GW, Jennings SG, Wunderink RG. The impart of blood cultures on antibiotic therapy in pneumococcal pneumonia. Chest. 1999;116:1278–1281
  5. Skerrett SJ. Diagnostic testing for community-acquired pneumonia. Clin Chest Med. 1999;20:531–548
  6. Fine MJ, Smith MA, Carson CA. Prognosis and outcomes of patients with community-acquired pneumonia. JAMA. 1996;275:134–141
  7. Rello J, Quintana E, Ausina V. A 3-year study of severe community-acquired pneumonia with emphasis on outcome. Chest. 1993;103:232
  8. Potgrieter PD, Hammond J MJ. Etiology and diagnosis of pneumonia requiring ICU admission. Chest. 1992;101:199
  9. Ruiz M, Ewig S, Torres A. Severe community-acquired pneumonia. Am J Respir Crit Care Med. 1999;160:923–929
  10. Fine MJ, Auble TE, Yealy DM. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243–250
  11. Morb Mort Wkly Rep. 1992;41:RR–17
  12. Knaus WA, Draper EA, Wagner DP. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–829
  13. Marston BJ, Plouffe JF, File TM. Incidence of community-acquired pneumonia requiring hospitalisation. Arch Intern Med. 1997;157:1709–1718
  14. Mundy LM, Auwaerter PG, Oldach D. Community-acquired pneumonia: Impact of immune status. Am J Respir Crit Care Med. 1995;152:1309–1315
  15. Neill AM, Martin IR, Weir R. Community-acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax. 1996;51:1010–1016
  16. Sanyal S, Smith PR, Saha AC. Initial microbliologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am J Respir Crit Care Med. 1999;160:346–348
  17. Lim I, Shaw DR, Stanley DP. A prospective hospital study of the aetiology of community-acquired pneumonia. Med J Aust. 1989;151:87–91
  18. Kalin M, Lindberg AA. Diagnosis of pneumococcal pneumonia: a comparison between microscopic examination of expectorate, antigen detection and cultural procedures. Scand J Infect Dis. 1983;15:247–255
  19. Torres A, Serra-Batlles J, Ferrer A. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis. 1991;144:312–318
  20. Lorey O, Georges H, Beuscart C. Severe community-acquired pneumonia in ICU's: prospective validation of a prognostic score. Intensive Care Med. 1996;22:1307–1314
  21. Austrian R, Gold J. Pneumococcal bacteremica with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 1964;60:759–776
  22. Bartlett JG. Legionnaires' disease: overtreated, underdiagnosed. J Crit Illness. 1993;8:755–768
  23. Winston LG, Perlman JL, Rose DA. Penicillin-nonsusceptible Streptococcus pneumoniae at San Francisco General Hospital. Clin Infect Dis. 1999;29:580–585

☆ Correspondence should be addressed to: Dr Waterer, Methodist Le Bonheur Healthcare, 1265 Union Ave, 501 Crews Wing, Memphis, TN 38104-2499, U.S.A. Fax: +1-901-726-2456; E-mail: waterer@attglobal.net

PII: S0954-6111(00)90977-6

doi: 10.1053/rmed.2000.0977

Respiratory Medicine
Volume 95, Issue 1 , Pages 78-82 , January 2001

Article Tools